Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 3/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3195033 | 0.91 | LMNA (0.38) | CA2LMNATAAR1 | |
| SCHEMBL4848522 | 0.86 | CA2 (0.34) | CA2CA1LMNATAAR1L3MBTL1 | |
| SCHEMBL11207785 | 0.85 | THRA (0.35) | LMNA | |
| SCHEMBL6671164 | 0.82 | TAAR1 (0.48) | CA2LMNATAAR1L3MBTL1 | |
| SCHEMBL22825991 | 0.82 | CA2 (0.34) | CA2CA1LMNATAAR1L3MBTL1 | |
| SCHEMBL926567 | 0.81 | CA2 (0.37) | CA2CA1TAAR1L3MBTL1 | |
| SCHEMBL8850274 | 0.80 | LMNA (0.33) | LMNA | |
| SCHEMBL11848944 | 0.80 | CA1 (0.33) | CA2CA1LMNA | |
| SCHEMBL4850067 | 0.79 | TSHR (0.38) | TAAR1 | |
| SCHEMBL523595 | 0.79 | TDP1 (0.48) | LMNATAAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7463400-B1 | Electrochromic display device | FUJI XEROX CO., LTD. (JP) | 2008-12-09 | — | — | US | disclosed |
| US-7053167-B2 | Silsesquioxane derivative having functional group | CHISSO CORPORATION (JP) | 2006-05-30 | — | — | US | disclosed |
| US-20060089504-A1 | Silsesquioxane derivative having functional group | ITO KENYA | 2006-04-27 | — | — | US | disclosed |
| EP-0969007-B1 | Method of making an aromatic chlorosilane compound by a hydrosilation reaction | DOW CORNING ASIA LTD (JP) | 2004-09-22 | — | — | EP | disclosed |
| US-20040068074-A1 | Production process for silsesquioxane derivative having functional group and silsesquioxane derivative | JNC CORPORATION (JP) | 2004-04-08 | — | — | US | disclosed |
| US-6284365-B1 | FOR CONTROLLING PHYSICAL PROPERTIES OF SURFACE AND INTERFACE OF SOLID ARTICLE SUCH AS WETTABILITY, ADHESIVE PROPERTY, SURFACE ENERGY, DISPERSABILITY, CHEMICAL RESISTANCE | FUJI XEROX CO., LTD. (JP) | 2001-09-04 | — | — | US | disclosed |
| US-6054602-A | Method of making an aromatic chlorosilane compound by a hydrosilation reaction | DOW CORNING ASIA, LTD. (JP) | 2000-04-25 | — | — | US | disclosed |
| EP-0969007-A2 | Method of making an aromatic chlorosilane compound by a hydrosilation reaction | Dow Corning Asia, Ltd. (JP) | 2000-01-05 | — | — | EP | disclosed |
| US-5298532-A | Vinyl-siloxane block polymer, release coating | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1994-03-29 | — | — | US | disclosed |
| US-5093385-A | Block Polymerization | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1992-03-03 | — | — | US | disclosed |
| EP-0434335-A2 | A method of accelerating photoiniferter polymerization, polymer produced thereby, and product produced therewith | MINNESOTA MINING AND MANUFACTURING COMPANY (US) | 1991-06-26 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060089504-A1 | Silsesquioxane derivative having functional group | SFXN1, STS, SRM | CA2 35/4885CA1 24/4885LMNA 2228/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.